368 related articles for article (PubMed ID: 15129647)
1. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
2. Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2.
Ye J; Xie L; Green PL
J Virol; 2003 Jul; 77(14):7728-35. PubMed ID: 12829812
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.
Panfil AR; Al-Saleem J; Howard CM; Mates JM; Kwiek JJ; Baiocchi RA; Green PL
Viruses; 2015 Dec; 8(1):. PubMed ID: 26729154
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis.
Sieburg M; Tripp A; Ma JW; Feuer G
J Virol; 2004 Oct; 78(19):10399-409. PubMed ID: 15367606
[TBL] [Abstract][Full Text] [Related]
5. Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.
Mahgoub M; Yasunaga JI; Iwami S; Nakaoka S; Koizumi Y; Shimura K; Matsuoka M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1269-E1278. PubMed ID: 29358408
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and treatment of human T-cell leukemia virus infection.
Ratner L
Immunol Res; 2005; 32(1-3):217-23. PubMed ID: 16106073
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis in 12 patients with adult T cell leukemia/lymphoma confirmed by HTLV-1 provirus gene detection].
Wu ZJ; Zheng XY; Yang XZ; Liu TB; Yang T; Zheng ZH; Gao F; Chen CX; Li JG; Zhang CQ; Lin WQ; Zheng HY; Lin SX; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1027-1032. PubMed ID: 28088963
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro.
Tripp A; Liu Y; Sieburg M; Montalbano J; Wrzesinski S; Feuer G
J Virol; 2003 Nov; 77(22):12152-64. PubMed ID: 14581552
[TBL] [Abstract][Full Text] [Related]
9. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 infection of myeloid cells: from transmission to immune alterations.
Rocamonde B; Carcone A; Mahieux R; Dutartre H
Retrovirology; 2019 Dec; 16(1):45. PubMed ID: 31870397
[TBL] [Abstract][Full Text] [Related]
11. Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies.
Rosadas C; Menezes MLB; Galvão-Castro B; Assone T; Miranda AE; Aragón MG; Caterino-de-Araujo A; Taylor GP; Ishak R
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009717. PubMed ID: 34555019
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL).
Matsuoka M
Retrovirology; 2005 Apr; 2():27. PubMed ID: 15854229
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell lymphotropic virus type 1 and its oncogenesis.
Zhang LL; Wei JY; Wang L; Huang SL; Chen JL
Acta Pharmacol Sin; 2017 Aug; 38(8):1093-1103. PubMed ID: 28392570
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.
Nagata K; Tezuka K; Kuramitsu M; Fuchi N; Hasegawa Y; Hamaguchi I; Miura K
J Virol; 2024 Feb; 98(2):e0186223. PubMed ID: 38294250
[TBL] [Abstract][Full Text] [Related]
15. Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma.
Ghorbanzadeh Neghab M; Jalili-Nik M; Soltani A; Afshari AR; Hassanian SM; Rafatpanah H; Rezaee SA; Sadeghnia HR; Ataei Azimi S; Mashkani B
Biofactors; 2023; 49(6):1174-1188. PubMed ID: 37345860
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.
Jo T; Kubota-Koketsu R; Kaneko Y; Sakai T; Noguchi K; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
Cancer Immunol Immunother; 2023 Apr; 72(4):929-944. PubMed ID: 36181532
[TBL] [Abstract][Full Text] [Related]
17. A Textbook Case of Human T-lymphotropic Virus-1 (HTLV-1)-Induced Adult T-cell Leukemia Treated With Cyclophosphamide, Hydroxydaunorubicin, Oncovin, and Prednisone/Prednisolone (CHOP).
Altaf F; Qureshi ZA; Moore S; Golek TM; Chawala A
Cureus; 2023 Nov; 15(11):e49169. PubMed ID: 38024023
[TBL] [Abstract][Full Text] [Related]
18. Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.
Stufano A; Jahantigh HR; Cagnazzo F; Centrone F; Loconsole D; Chironna M; Lovreglio P
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578335
[TBL] [Abstract][Full Text] [Related]
19. Signaling factors potentially associated to the pathogenesis of Adult T-cell leukemia /lymphoma: A network-analysis and novel findings assessment.
Mozhgani SH; Zarei Ghobadi M; Norouzi M; Rahimi H; Valizadeh N; Teymoori-Rad M; Tarokhian H; Ostadali M; Farajifard H; Rezaee SA
Virus Res; 2022 Oct; 319():198875. PubMed ID: 35868352
[TBL] [Abstract][Full Text] [Related]
20. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki.
Hino S
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(4):152-66. PubMed ID: 21558754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
